Skip to main content
Article thumbnail
Location of Repository

Relationship of blood pressure, antihypertensive therapy, and outcome in ischemic stroke treated with intravenous thrombolysis: retrospective analysis from Safe Implementation of Thrombolysis in Stroke-International Stroke Thrombolysis Register (SITS-ISTR)

By N. Ahmed, G.A. Ford, M. Kaste, K.R. Lees and D. Toni


<p><b>Background and Purpose:</b> The optimal management of blood pressure (BP) in acute stroke remains unclear. For ischemic stroke treated with intravenous thrombolysis, current guidelines suggest pharmacological intervention if systolic BP exceeds 180 mm Hg. We determined retrospectively the association of BP and antihypertensive therapy with clinical outcomes after stroke thrombolysis.</p>\ud \ud <p><b>Methods:</b> The SITS thrombolysis register prospectively recorded 11 080 treatments from 2002 to 2006. BP values were recorded at baseline, 2 hours, and 24 hours after thrombolysis. Outcomes were symptomatic (National Institutes of Health Stroke Scale score deterioration &#8805;4) intracerebral hemorrhage Type 2, mortality, and independence at (modified Rankin Score 0 to 2) 3 months. Patients were categorized by history of hypertension and antihypertensive therapy within 7 days after thrombolysis: Group 1, hypertensive treated with antihypertensives (n=5612); Group 2, hypertensive withholding antihypertensives (n=1573); Group 3, without history of hypertension treated with antihypertensives (n=995); and Group 4, without history of hypertension not treated with antihypertensives (n=2632). For 268 (2.4%) patients, these data were missing. Average systolic BP 2 to 24 hours after thrombolysis was categorized by 10-mm Hg intervals with 100 to 140 used as a reference.</p>\ud \ud <p><b>Results:</b> In multivariable analysis, high systolic BP 2 to 24 hours after thrombolysis as a continuous variable was associated with worse outcome (P&#60;0.001) and as a categorical variable had a linear association with symptomatic hemorrhage and a U-shaped association with mortality and independence with systolic BP 141 to 150 mm Hg associated with most favorable outcomes. OR (95% CI) from multivariable analysis showed no difference in symptomatic hemorrhage (1.09 [0.83 to 1.51]; P=0.58) and independence (1.03 [0.93 to 1.10]; P=0.80) but lower mortality (0.82 [0.73 to 0.92]; P=0.0007) for Group 1 compared with Group 4. Group 2 had a higher symptomatic hemorrhage (1.86 [1.34 to 2.68]; P=0.0004) and mortality (1.62 [1.41 to 1.85]; P&#60;0.0001) and lower independence (0.89 [0.80 to 0.99]; P=0.04) compared with Group 4. Group 3 had similar results as Group 1.</p>\ud \ud <p><b>Conclusions:</b> There is a strong association of high systolic BP after thrombolysis with poor outcome. Withholding antihypertensive therapy up to 7 days in patients with a history of hypertension was associated with worse outcome, whereas initiation of antihypertensive therapy in newly recognized moderate hypertension was associated with a favorable outcome.</p

Publisher: American Heart Association
Year: 2009
OAI identifier:
Provided by: Enlighten

Suggested articles


  1. (1993). Acute hypertension after stroke: the scientific basis for treatment decisions. doi
  2. Alexandrov AV. Association of pretreatment blood pressure with tissue plasminogen activator-induced arterial recanalization in acute ischemic stroke. doi
  3. Alexandrov AV. Is the benefit of early recanalization sustained at 3 months? A prospective cohort study. doi
  4. Association of characteristics of blood pressure profiles and stroke outcomes in the ECASS-II trial. doi
  5. Blood flow and vascular reactivity in collaterally perfused brain tissue. Evidence of an ischemic penumbra in patients with acute stroke. doi
  6. Blood pressure after stroke.
  7. (1998). Blood pressure and functional recovery in acute ischemic stroke. Stroke. doi
  8. Blood pressure and vessel recanalization in the first hours after ischemic stroke. doi
  9. Blood pressure course in patients with acute stroke and matched controls. doi
  10. Blood pressure decrease during the acute phase of ischemic stroke is associated with brain injury and poor stroke outcome. doi
  11. (2004). Blood pressure, nimodipine, and outcome of ischemic stroke. Acta Neurol Scand. doi
  12. (1991). Cerebral hemodynamics in ischemic cerebrovascular disease. Ann Neurol. doi
  13. Characteristics of blood pressure profiles as predictors of long-term outcome after acute ischemic stroke. doi
  14. Community-based thrombolytic therapy of acute ischemic stroke in Helsinki. doi
  15. Demchuk AM, Alexandrov AV. Clinical deterioration after intravenous recombinant tissue plasminogen activator treatment: a multicenter transcranial Doppler study. doi
  16. Effect of blood pressure during the acute period of ischemic stroke on stroke outcome: a tertiary analysis of the doi
  17. Effect of intravenous nimodipine on blood pressure and outcome after acute stroke. doi
  18. (2004). Factors influencing acute blood pressure values in stroke subtypes. J Hum Hypertens. doi
  19. Group. COSSACS (Continue or Stop post-Stroke Antihypertensives Collaborative Study): rationale and design. doi
  20. Hypertension and its treatment in the NINDS rt-PA Stroke Trial. doi
  21. Interventions for deliberately altering blood pressure in acute stroke. Cochrane Database Syst Rev. doi
  22. Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke. doi
  23. Investigators. Glyceryl trinitrate vs control, and continuing vs. stopping temporarily prior antihypertensive therapy, in acute stroke: rationale and design of the Efficacy of Nitric Oxide doi
  24. Magnesium for acute stroke (Intravenous Magnesium Efficacy in Stroke trial): randomised controlled trial. doi
  25. Multivariable analysis of outcome predictors and adjustment of main outcome results to baseline data profile in randomized controlled trials: Safe Implementation of Thrombolysis doi
  26. (2008). Organisation (ESO) Executive Committee; ESO Writing Committee. Guidelines for management of ischaemic stroke and transient ischaemic attack 2008. Cerebrovasc Dis. doi
  27. (1994). T; for the INWEST study group. The Intravenous Nimodipine West European Trial (INWEST) of nimodipine in the treatment of acute ischemic stroke. Cerebrovasc Dis. doi
  28. (2003). Thrombolysis for acute ischaemic stroke. Cochrane Database Syst Rev. doi
  29. (2009). Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. doi
  30. Thrombolysis with alteplase 3–4.5 h after acute ischaemic stroke (SITS-ISTR): an observational study. doi
  31. (2007). Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in StrokeMonitoring Study (SITS-MOST): an observational study. Lancet. doi
  32. (1995). Tissue plasminogen activator for acute ischemic stroke. doi
  33. (1998). Two-sided confidence intervals for the single proportion: comparison of seven methods. Stat Med. doi

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.